Results

Total Results: 1,134 records

Showing results for "days".

221. Ch 4-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
     January 01, 2010 - levels may be monitored, pill counts may be performed, and medications may be dispensed in limited days … ICS ranged from ever having used ICS to use during the entire study period to use in the last 365 days … to use in the last 30 days. … strength of each dose from the NDC code, dose strength can be combined with quantity dispensed and days

222. Alcohol-Misuse-Drug-Therapy Consumer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_consumer.pdf
     February 01, 2016 - Medicines To Treat Alcohol Use Disorder A Review of the Research for Adults Is This Information Right for Me? Yes, this information is right for you if: � Your doctor* said you have alcohol use disorder and need to stop drinking or cut down the amount you drink. � You have decided to stop or cut down your dri…

223. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - treated with the drug were reported to have a longer median time to the first exacerbation (266 days … vs. 174 days) and less-frequent exacerbations than patients treated with placebo. … The median time to first exacerbation was 266 days (95% confidence interval [CI], 227 to 313) among … patients treated with azithromycin and 174 days (95% CI, 143 to 215) among patients receiving placebo … transplantation.26 Warnecke and co-authors reported that “all grafts and patients (n=12) survived to 30 days

224. Acs-Pci-Adjunctive-Devices Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_surveillance.pdf
     April 01, 2013 - When we evaluated mortality and MACE in studies of 365 days or longer, we saw no significant difference … aspiration thrombectomy, bolus intracoronary abciximab or both 452 Infarct size was smaller at 30 days … When we evaluated mortality and MACE in studies of 365 days or longer, we saw no significant difference

225. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-disposition.pdf
     June 22, 2017 - National Surgical Quality Improvement Project (NSQIP) 2015 expected rate for orthopaedic VTE within 30 days … The NQF 1550 quality measure includes: (1) Mechanical complications (90 days) (2) Periprosthetic joint … infection (90 days) (3) Wound infection (90 days) (4) Surgical site bleeding (30 days) (5) Pulmonary … embolism (30 days) (6) Death (30 days) (7) Acute myocardial infarction (7 days) (8) Pneumonia (7 … days) (9) Sepsis/septicemia (7 days).

226. Disposition of Comments Report for Screening, Behavioral Counseling, and Referral in Primary Care To Reduce Alcohol Misuse (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_disposition-comments.pdf
     July 10, 2012 - (in other words, if a study result for change in heavy drinking days ranged (95% confidence interval … ) from -3 to +2, the potential harm would be an increase in heavy drinking days plausible within a … vs 20 days; P = 0.04) and decreased the median number of any drinking days per month by 90% (0.7 vs … 7.2; P = 0.005) and heavy drinking days per month by 93% (0.2 days vs 2.9 days; P = 0.007). … drinking days in patients who were abstinent for as few as 4 days before treatment initiation.

227. Masks-Appendix-Table-B-2-Surveillance-Report (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-2-surveillance-report.xlsx
     March 01, 2020 - Beijing) Community Family members who had lived with primary (index) cases of COVID-19 in a house for 4 days

228. Masks-Surveillance-2-Appendix-Table-A-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-2.xlsx
     March 01, 2020 - Beijing) Community Family members who had lived with primary (index) cases of COVID-19 in a house for 4 days

229. Enhanced Functionality for the Distributed Research Network Pilot (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-expansion_research.pdf
     April 01, 2012 - In addition, this notification also occurs when a data mart has not responded within n days of the … The submitter will receive one notification per query submitted, which occurs n days after the last … The submitter will receive one notification per query submitted, which occurs n days after the last … Available frequency in days EventTypeId Unique Id for EventTypes that the frequency is associated … The frequency of such reminders shall be set to preferred frequency (in days) from the available list

230. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-2005_executive.pdf
     January 01, 2005 - The most commonly reported complications occurring intraoperatively or within 30 days after open fundoplication … Frequently reported complications for endoscopic treatments—intraoperatively or within 30 days after

231. Treating and Preventing C. difficile Infections (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_consumer.pdf
     May 01, 2017 - The most common symptoms of CDI include watery diarrhea (three or more times a day for 2 or more days … You may be at a higher risk for getting CDI if you: � Have taken antibiotics in the past 30 days

232. Executive Summary_Comparative Effectiveness Review No. 259: Partial Breast Irradiation for Breast Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-259-partial-breast-irradiation-executive-summary.pdf
     January 01, 2023 - fractionated WBI over several weeks, accelerated PBI was associated with lower transportation costs and days … with standard fractionation WBI, accelerated PBI was associated with lower transportation costs and days

233. The Effectiveness of Indoor Allergen Reduction and the Role of Bronchial Thermoplasty in the Management of Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-nonpharmacologic-treatment_research-protocol.pdf
     October 04, 2016 - studies § Individual measures r Spirometry r Coughing r Wheezing r Nighttime waking r Symptom free days … r Maximum symptom days r Airway hyperresponsiveness r Growth indicators (pediatric patients) o … PAQLQ) § Pediatric Asthma Caregivers Asthma Quality of Life Questionnaire (PACQLQ) § Asthma-specific days … o Emergency/urgent care o Intensive care/intubation • Quality of life o Patient-reported survey o Days … o Emergency/urgent care o Intensive care/intubation • Quality of life o Patient-reported survey o Days

234. S108 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s108.pdf
     October 01, 2007 - The values for V(t) and A(t) were updated at intervals of 0.25 days. … Severity of illness was assumed to be constant between intervals of 0.25 days. … The discharge hazard rate was set to produce an average length of stay of approximately 5.5 days when … itself had no effect, length of stay was longer in individuals who experi- enced an adverse event (10.51 days … ), compared with individ- uals who did not experience an adverse event (3.62 days).

235. Hunt_Panel_1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/hunt_panel_1.pdf
     January 01, 2010 - Hunt_Panel_1 Slide  1: Helping  People  Make  Better Health Care  Choices: Why  Web 2.0? Yvonne Hunt, Ph.D., M.P.H. Cancer Prevention Fellow National Cancer Institute, Bethesda, MD Slide  2: Untitled page from the smokefree.gov Web site. Slide  3…

236. Postpartum Care for Women Up to One Year After Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
     April 25, 2022 - birth.9-12 In addition, federal Medicaid coverage for pregnant individuals currently ends after 60 days … percent of pregnancy-related deaths occurring in the postpartum period, 19 percent occur in the first 6 days … after birth, 21 percent between 7 and 42 days, and 12 percent between 43 days and 1 year.17 A 2018 … Does this relationship differ by timing of outcomes, specifically within 6 days postpartum, between

237. Cannabis-2023-Surv-Rep-4-Table-E-5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
     January 01, 2023 - Baseline: 1,514 4-year followup: 1,217 Groups unclear A: Self-reported frequent cannabis use (≥20 days

238. Cannabis-2022-Surv-Rep-4-Table-F5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-table-F5.xlsx
     January 01, 2022 - Baseline: 1,514 4-year followup: 1,217 Groups unclear A: Self-reported frequent cannabis use (≥20 days

239. Slide 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
     August 27, 2012 - Slide 1 Research Triangle Institute RTI International is a trade name of Research Triangle Institute. www.rti.org The Use of Conjoint Analysis to Elicit Patient Preferences in Selecting Treatment Endpoints F. Reed Johnson, PhD Distinguished Fellow and Principal Economist Research Triangle Institute I…

240. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - not need updating Hawthorn Hawthorne (84.3 mg/day of oligomeric procyanidines) + digoxin (21 days … ) versus digoxin alone (10 days): no significant differences in pharmacokinetic outcomes. … New Evidence: Hawthorn Hawthorne (84.3 mg/day of oligomeric procyanidines) + digoxin (21 days … ) versus digoxin alone (10 days): no significant differences in pharmacokinetic outcomes.